Half-Life of Immediate-Release Oxycodone
The elimination half-life of immediate-release (IR) oxycodone is 3.5 to 4 hours 1.
Pharmacokinetic Details
According to FDA labeling data, the apparent elimination half-life following administration of oxycodone hydrochloride tablets ranges from 3.5 to 4 hours 1. More granular data from the same FDA sources show slight variations by dose and formulation:
- 5 mg tablets (×3): 3.73 ± 0.9 hours
- 15 mg tablet: 3.55 ± 1.0 hours
- 30 mg tablet: 3.85 ± 1.3 hours
- Oral solution (fasted): 2.9 ± 0.4 hours
- Oral solution (fed): 3.3 ± 0.5 hours 1
Clinical Implications
Withdrawal Timing
Understanding the half-life is critical when managing opioid discontinuation. Withdrawal symptoms begin 2-3 half-lives after the last dose 2. For oxycodone IR with a 3-4 hour half-life, this means:
- Symptom onset: 6-12 hours after last dose
- Peak symptoms: 48-72 hours
- Resolution: 7-14 days 2
Dosing Considerations
The relatively short half-life means:
- Steady-state achievement: Approximately 18-24 hours with regular dosing 1
- No significant accumulation with standard every-4-to-6-hour dosing 1
- IR formulations should never be used for acute pain management as extended-release/long-acting opioids due to this shorter duration 3
Important Caveats
Hepatic impairment: Clearance may decrease significantly since oxycodone undergoes extensive hepatic metabolism via CYP3A4 and CYP2D6, potentially prolonging the half-life 1.
Renal impairment: The drug is substantially excreted by the kidney, and impaired renal function increases risk of adverse reactions, likely affecting elimination 1.
Interindividual variation: Research confirms marked variability in pharmacokinetics (elimination half-life ranging from 3.01 ± 1.37 hours IV to 3.51 ± 1.43 hours PO in cancer patients), supporting the need for individualized monitoring 4.